	US 11,696,891 B2
	Glucono delta-lactone for treatment of vaginal fungal infections
Ulf Ellervik, Loddekopinge (SE); Olov Sterner, Malmo (SE); Helena Strevens, Lund (SE); and Sophie Manner, Helsingborg (SE)
Assigned to Gedea Biotech AB, Lund (SE)
Filed by Gedea Biotech AB, Lund (SE)
Filed on Mar. 31, 2021, as Appl. No. 17/218,739.
Application 17/218,739 is a continuation of application No. 16/089,194, granted, now 10,993,907, previously published as PCT/EP2017/058268, filed on Apr. 6, 2017.
Claims priority of application No. 1650467-2 (SE), filed on Apr. 6, 2016.
Prior Publication US 2021/0212937 A1, Jul. 15, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/00 (2006.01); A61K 31/366 (2006.01); F27D 1/16 (2006.01); F27B 14/10 (2006.01); F27B 14/06 (2006.01); A61P 31/10 (2006.01); A61K 9/02 (2006.01); H05B 6/24 (2006.01); A61K 9/20 (2006.01); A61K 31/351 (2006.01); A61K 31/4164 (2006.01); A61K 31/496 (2006.01); A61K 31/513 (2006.01); A61K 31/7004 (2006.01); F27B 14/00 (2006.01); F27B 3/12 (2006.01); A61K 31/4174 (2006.01); A61K 31/4196 (2006.01); F27B 14/08 (2006.01)

CPC A61K 9/0036 (2013.01) [A61K 9/0034 (2013.01); A61K 9/02 (2013.01); A61K 9/20 (2013.01); A61K 31/351 (2013.01); A61K 31/366 (2013.01); A61K 31/4164 (2013.01); A61K 31/4174 (2013.01); A61K 31/4196 (2013.01); A61K 31/496 (2013.01); A61K 31/513 (2013.01); A61K 31/7004 (2013.01); A61P 31/10 (2018.01); F27B 3/12 (2013.01); F27B 14/00 (2013.01); F27B 14/061 (2013.01); F27B 14/10 (2013.01); F27D 1/1626 (2013.01); H05B 6/24 (2013.01); F27B 2014/066 (2013.01); F27B 2014/0837 (2013.01)]

16 Claims

1. A method for treatment of a fungal infection consisting of administering to a subject in need thereof a pharmaceutical formulation consisting of an antifungal agent of Glucono δ-lactone (formula (III)

alone or in combination with gluconic acid, glucono-γ-lactone, or both, and one or more pharmaceutically acceptable excipients; and

treating said fungal infection in said subject by said administering.